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Low dose spinal morphine and intravenous diclofenac
for postoperative analgesia after total hip and knee
arthroplasty
Abstract
Background and Aims: Intrathecal (IT) morphine added to a spinal
anaesthesia provides effective postoperative analgesia after hip and knee
arthroplasty reducing the need for systemic opioids. To reduce the risk of side
effects like pruritus, nausea/vomiting, and a more serious effect of respira-
tory depression, low dose IT morphine (0,1–0,3 mg) has been used. The aim
of this prospective, randomized, double-blind study was to assess the analge-
sic efficacy of 0,2 mg IT morphine combined with postoperative i.v. diclo-
fenac in the first 24 hours after hip and knee arthroplasty, the primary out-
come measure being the number of patients without any additional opioid
request. Side effects and possible complications of therapy and patient satis-
faction with pain management were also recorded.
Patients and Methods: 40 patients were randomized to receive spinal
anaesthesia with levobupivacaine and 0,2 mL normal saline (control group)
or 0,2 mg IT morphine. All patients received diclofenac 75 mg i.v. one and
10 hours postoperatively. Pain was assessed by numeric rating scale at 3,6,12
and 24 hours postoperatively and morphine 2 mg i.v. was given for inade-
quate analgesia. The third dose of diclofenac could be given 10–12 hours af-
ter the second dose for a pain score 3–4.
Results: IT morphine group had significantly lower postoperative pain
scores at all measured time intervals and used significantly less i.v. mor-
phine. 76,2% of patients in the IT morphine group did not require any ad-
ditional i.v. morphine compared to 11,1% of the control group. This re-
sulted in significantly higher patient satisfaction despite common occurence
of mild pruritus. Postoperative nausea/vomiting were frequent in both
groups with no cases of respiratory depression.
Conclusions: Low dose IT morphine added to regular postoperative i.v.
diclofenac provides excellent analgesia after hip and knee arthroplasty and
allows for a protocol without additional systemic opioids.
INTRODUCTION
In recent years considerable attention has been paid to the treatmentof postoperative pain with regard to the favourable effect of adequate
analgesia on patient outcome. The provision of high quality analgesia
after major orthopaedic surgery in older patients with comorbidities
still presents a challenge. Intrathecal (IT) opiates, especially morphine,
provide effective analgesia in patients undergoing total hip and knee
arthroplasty in spinal anaesthesia (1, 2). However, IT morphine may be
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associated with dose related side effects like nausea and
vomiting, pruritus, urinary retention and the most con-
cerning adverse effect of delayed respiratory depression.
In an attempt to reduce side effects and complications
low doses of IT morphine ranging from 0,1–0,3 mg have
been used with favourable results (3–7). Even at low
doses IT morphine produced effective pain relief in the
first 24 postoperative hours with lower pain scores, de-
creased requirement for systemic opioids and high pa-
tient satisfaction. Some patients did not require any sys-
temic opioids during 24 hours after surgery. Several dose
ranging studies have looked into the lowest effective dose
of IT morphine in patients undergoing total hip and
knee replacement (3, 4, 6–8). While 0,1 mg of IT mor-
phine provides good analgesia after hip arthroplasty, knee
arthroplasty requires doses of 0,2–0,3 mg for effective
pain relief. In an attempt to improve postoperative anal-
gesia several authors have used paracetamol, metamizol
or nonsteroidal antiinflammatory drugs (NSAIDs) i.e.
nonopioid analgesics in addition to IT and systemic
opioids with further benefitial effects (8–10). Multicen-
tre study on orthopaedic patients (9) which used 0,1 mg
and 0,2 mg of IT morphine and i.v. metamizol for post-
operative pain management showed 40% of patients did
not require any additional systemic opioids postopera-
tively.
The aim of this prospective, randomized, double-blind
study was to assess the analgesic efficacy of low dose IT
morphine (0,2 mg) combined with postoperative i.v. di-
clofenac in the first 24 hours after total hip and knee re-
placement. We also recorded side effects and possible
complications of IT and systemic morphine use and pa-
tient satisfaction with pain management.
PATIENTS AND METHODS
The study protocol was approved by the Hospital
Ethics Committee and informed consent was obtained
from all patients before the study. 40 adult patients ASA
physical status I–III scheduled for total hip or knee re-
placement surgery during spinal (intrathecal) anaesthe-
sia were enrolled in the study in a prospective, random-
ized, double blinded manner. Exclusion criteria were as
follows: any medical condition resulting in ASA status
greater than 3, non-suitability for spinal anaesthesia as
deemed by the anaesthesiologist providing care for the
patient, history of adverse reaction or a contraindication
to the administration of morphine, diclofenac or local
anaesthetic agents and preoperative use of strong opioids.
No patient received a premedication. Spinal anaes-
thesia was performed with the patient in the sitting posi-
tion at spinal levels L 3/4 or L 4/5. Patients were adminis-
tered 13,5–15 mg of isobaric levobupivacaine (Chiro-
caine 5 mg/mL, Abbot, Italy) mixed with the study medi-
cation which was 0,2 mg of preservative-free morphine
chloride (Morfinklorid Alkaloid 4 mg/mL, Alkaloid,
Skopje, Republic of Macedonia) made up to 0,2 mL with
normal saline in the morphine group or 0,2 mL of nor-
mal saline in the control group. The remainder of the
intraoperative anaesthetic care was left to the discretion
of the anaesthesiologist caring for the patient. All pa-
tients received indwelling urinary catheter preoperati-
vely. Postoperatively patients were transfered to the high
dependency unit for 24 hours where respiratory and
haemodynamic parameters were monitored regularly.
Standard monitoring included continuous ECG, respi-
ratory rate, peripheral oxygen saturation (pulse oxyme-
try) monitoring and hourly, or more frequent, blood
pressure measurements. All patients received oxygen via
nasal canula at 3 L/min for the first 2 hours and later for
oxygen saturation  93%, 75 mg of diclofenac sodium in
100 mL of saline infused over 30 minutes and 10 mg of
metoclopramide i.v. at 1 and 10 hours postoperatively.
Assessment variables included the severity of pain, the
presence and severity of postoperative nausea and vomit-
ing (PONV), pruritus, sedation and respiratory depres-
sion. Each variable was recorded at the time of admission
to the unit (time 0), at 3, 6, 12 and 24 hours postopera-
tively or more frequently if treatment was required. Pain
severity was evaluated by using a numeric rating scale
(NRS), previously explained to the patient. On NRS 0
denotes no pain and 10 denotes the most severe pain.
The NRS was chosen for pain assessment, as it was
found to be easier to use than the visual analogue scale in
elderly patients, who frequently suffer visual and coordi-
nation difficulties. Patients with a NRS score ? 4 or pa-
tients who requested analgesic were administered 2 mg
i.v. morphine bolus with a minimal interval of 15 min-
utes between each bolus. For pain with NRS score 3–4,
12 or more hours after the second dose of diclofenac, an
additional 75 mg of diclofenac could be administered. 24
hours after the surgery patients were asked about their
postoperative pain experience (worse then expected, as
expected, less then expected).
The incidence and severity of PONV and pruritus
were graded as follows: 0 = none; 1 = mild, no treat-
ment requested by patient; 2 = moderate to severe, treat-
ment requested by patient. First line treatment of PONV
consisted of 6,5 mg of thiethylperazine, a phenothiazine,
intravenously. Dexamethasone 8 mg i.v. was a second
line therapy and if both proved unsuccessful, morphine
was switched for another opioid (tramadol or meperi-
dine). Treatment for pruritus consisted of 20 mg of chlo-
ropyramine, an antihistaminic, intravenously. Naloxone
in increments of 0,04 mg was reserved for chloropyra-
mine resistant pruritus. Sedation was scored on a scale
0–3 (0 = awake, 1 = dozing intermittently, 2 = mostly
sleeping, 3 = difficult to waken). Significant sedation
was defined as a sedation score of 3. Respiratory depres-
sion was defined as respiratory rate < 10 breaths per
minute or oxygen saturation  93% on oxygen 3 L/min
via nasal canula. For signifcant sedation and/or respira-
tory depression naloxone 0,1–0,4 mg i.v. was to be used.
The primary outcome variable was the number of pa-
tients without additional opioid request during the 24
hour study period. Secondary outcome measures inclu-
ded pain intensity 3,6,12 and 24 hours postoperatively,
the total amount of supplemental morphine, the time to
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first opioid request, the incidence of adverse effects and
patient perception of postoperative pain management.
The sample size was estimated from the published
studies of a similar design. Continuous numerical data
were analysed for the normality of distribution (Kolmo-
gorov-Smirnov test) and presented as mean ± S.D. Group
comparisons were performed using Student’s t-test. Cat-
egorical data were presented as raw data or as frequences
and analysed with the c2-test. Statistical significance was
defined as P value less than 0,05.
RESULTS
Forty patients were enrolled in the study and were
randomly assigned to IT morphine (21 patients) or con-
trol group (19 patients). No patient was excluded after
entering the study, only the data for 24 hour morphine
consumption from one patient in the control group were
not included in the analysis, because the patient had se-
vere PONV with i.v. morphine use and was switched to
i.v. tramadol. There were no significant differences in de-
mographic characteristics, ASA (American Association
of Anaesthesiologists) status or the type of operation i.e.
hip or knee surgery between the groups (Table 1).
Pain assessment by NRS at rest at different time inter-
vals after arrival to the unit is presented in Table 2. The
NRS scores were significantly lower in the IT morphine
group at 3, 6, 12 and 24 postoperative hours with P 
0,001. The mean worst postoperative NRS scores re-
ported in the control group were significantly higher (P
< 0,001) then those reported in the IT morphine group.
Maximal pain scores in control patients (NRS 6,08 ±
1,86) were unacceptably high and probably reflect the
delay in patient’s request for analgesia and the delay in
nurse administering the analgesic compared to patient-
-controlled analgesia. The 24 hour use of supplemental
morphine was significantly lower (P < 0,001) in the IT
morphine group then in the control group with a longer
time to the first request for supplemental morphine (Ta-
ble 3). In the IT morphine group 76,2 % of patients did
not require any systemic opioid in the first 24 postopera-
tive hours compared to only 2 patients (11%) in the con-
trol group, the difference being significant with P =
0,021. This correlated well with much higher proportion
of patients (81%) experiencing less pain than they had
expected compared to the control group (21,1%), P =
0,007. The incidence and severity of PONV were not dif-
ferent between the groups, while pruritus was signifi-
cantly more frequent in the IT morphine group (Table
4). However, in all patients pruritus was mild and did not
require treatment. The possible effect of IT morphine on
urinary retention could not be analysed as all patients
had urinary catheters placed preoperatively. None of the
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TABLE 1
Patient and surgery characteristics.
Control IT morphine P value
No. patients (% of total) 19 (47.5%) 21 (52.5%)
Age (years) 67.74 ± 6.32 68.05 ± 8.8 n.s.
Sex (M:F) 7:12 9:12 n.s.
Weight (kg) 85.95 ± 12.8 85.8 ± 12.91 n.s.
Height (cm) 164.89 ± 7.42 166.66 ± 10.73 n.s.
ASA grade
2 15 (37.5%) 17 (42.5%) n.s.
3 4 (10%) 4 (10%) n.s.
Surgery
Hip replacement 12 (30%) 15 (37.5%) n.s.
Knee replacement 7 (17.5%) 6 (15%) n.s.
Values are mean ± S.D. or number (proportion); IT = intrathecal; n.s. = non-significant
TABLE 2
Pain assessment by numeric rating scale (NRS) at rest at different times after surgery.
Time (hours) Control (n = 19) IT morphine (n = 21) P value
3 3.79 ± 2.21 0.93 ± 1.68 P < 0.001
6 4.2 ± 2.32 1.29 ± 1.42 P < 0.001
12 3.6 ± 2.21 1.50 ± 1.45 P = 0.001
24 4.21 ± 1.52 1.48 ± 1.6 P < 0.001
Max NRS 6.08 ± 1.86 2.79 ± 1.71 P < 0.001
Values are expressed as mean ± S.D.; IT = intrathecal
patients in the IT morphine or control group developed
respiratory depession or excessive sedation. There were
no other complications possibly related to the treatment
protocol and all patients were transfered to the regular
ward after 24 hours.
DISCUSSION
The main finding of the present study was that low
dose IT morphine (0,2 mg) added to regular postopera-
tive administration of NSAID diclofenac provided excel-
lent analgesia in the first 24 hours after total hip and knee
arthroplasty in spinal anaesthesia without significant ad-
verse affects. Effective postoperative analgesia manifested
itself in a high proportion of patients (76,2%) not requir-
ing any additional opioids during the 24 hour study pe-
riod and in high patient satisfaction with their pain man-
agement as they experienced less pain then they had
expected.
Intrathecal morphine was introduced into clinical pra-
ctice in 1979 (11) and has been shown to provide effective
and long lasting analgesia after a variety of surgical pro-
cedures. Although in some institutions IT opioids, typi-
cally morphine, are applied as a single-dose injection in
patients undergoing major surgery under general anaes-
thesia (12), more commonly they are added to intrathe-
cally injected local anaesthetics in patients undergoing
surgery in spinal anaesthesia like Caesarean section, or-
thopaedic surgery, urological and gynaecological surgery
(13–15).
Morphine is a highly hydrophilic opioid and applied
intrathecally it enters the spinal cord slowly producing
persistently high cerebrospinal fluid (CSF) concentra-
tions. This contributes to the longevity of its analgesic ac-
tion, but also to the risk of late respiratory depression due
to cephalad migration in the CSF. CSF opioid concen-
trations, analgesia and respiratory depression are dose
dependent and profound respiratory depression has been
reported in the earlier studies which used larger doses of
IT morphine i.e. more than 1 mg (16). Jacobson et al.
(16) suggested that the peak onset of respiratory depres-
sion was 5–10 hours after the injection. Also, respiratory
depression has been reported more commonly in studies
which used IT opioids to provide analgesia after major
surgery under general anaesthetic.
In an attempt to decrease the risk of respiratory de-
pression and other side effects of which pruritus seems to
be dose dependent, several dose ranging studies have
looked into the lowest effective dose of IT morphine after
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TABLE 3
Data regarding postoperative morphine requirement and overall patient assessment of pain in the first 24 hours.
Control (n = 19) IT morphine (n = 21) P value
Morphine consumption (mg) 6.28 ± 3.96 0.67 ± 1.32 P < 0.001
Patients without opioid request (% of the group) 2 (11.1%) 16 (76.2%) P < 0.021
Time to morphine request* (hours) 4.93 ± 7.06 19.7 ± 7.98 P < 0.001
Pain assessment
Less than expected 4 (21.1%) 17 (81%) P = 0.007
As expected 9 (47.4%) 4 (19%) P = 0.267
Worse than expected 6 (31.6%) 0 P = 0.031
Values are mean ± S.D. or number (proportion); IT = intrathecal
* If no morphine was given in 24 hours, the time was recorded as 24 hours
TABLE 4
Incidence of side effects in the first 24 postoperative hours.
Control (n = 19) IT morphine (n = 21) P value
PONV*
Mild (score 1) 6 (15%) 6 (15%) n.s.
Moderate to severe (score 2) 2 (5%) 3 (7.5%) n.s.
Pruritus*
Mild (score1) 9 (22.5%) 1 (2.5%) P = 0.021
Moderate to severe (score 2) 0 0
Resp. depression 0 0
Significant sedation* (score 3) 0 0
Values are number (proportion); IT = intrathecal; PONV = postoperative nausea and vomiting; n.s. = non-significant
* grading PONV, pruritus and sedation as described in methods
certain types of surgeries. The studies have shown that
even low dose IT morphine (0,1–0,3 mg) significantly re-
duced acute pain after total hip and knee arthroplasty
manifested by lower pain scores, decreased requirement
for systemic opioids via patient-controlled analgesia and
an increase in the time until first opioid request (3–8).
Similarly, in our study patients who received 0,2 mg IT
morphine with spinal anaesthetic had significantly lower
pain scores at all measured time intervals and used sig-
nificantly less systemic opioid during the study period.
However, when using low dose IT morphine there are
concerns about the appropriate choice of rescue analge-
sia if patients have ineffective pain relief because sys-
temic opioids can increase the risk of respiratory depres-
sion. Some authors have used the concept of multimodal
analgesia and regular doses of nonopioid analgesics like
paracetamol, metamizol or NSAIDs in addition to IT
morphine to improve the quality of analgesia and possi-
bly avoid the use of systemic opioids (8–10, 17). The
studies differed in the study population i.e. the type of
surgery and nonopioid analgesic used, but all have shown
the beneficial effect of combining IT morphine with
nonopioid analgesics. In the study in which they com-
pared 0,2 mg and 0,5 mg IT morphine for postoperative
analgesia after knee replacement, Bowrey et al. (8) used
oral paracetamol 1 g four times daily and diclofenac 50
mg three times daily. The efficacy of this protocol is ques-
tionable considering high frequency of PONV in this
and other studies on IT morphine. In a more recent
multicentric study on orthopaedic patients receiving me-
tamizol 1 g i.v. on a regular basis, Gehling and al. (9)
showed that 0,2 mg IT morphine significantly reduced
the number of patients requiring systemic opioids in the
first 24 hours (31%) compared to 0,1 mg IT morphine
(51%) or control group (76%). They concluded that in
patients receiving analgesia with a combination of IT
morphine and systemic nonopioid analgesia, the use of
patient-controlled analgesia device could be avoided. We
used NSAID diclofenac 75 mg administered intravenou-
sly in two doses, with possibly the third dose 10–12 hours
after the second dose for NRS score 3–4. This provided
highly effecient analgesia with 76,2% of patients not re-
quiring any additional opioid and 81% of patients being
very satisfied with their pain management as they experi-
enced less pain in the early postoperative period than
they had expected.
The most frequent side effects of opioid therapy are
nausea/vomiting and pruritus. The incidence and sever-
ity of nausea/vomiting in our study did not differ signifi-
cantly between the IT morphine and the control group
which received systemic opioids. This is consistent with
the results from other studies on orthopaedic patients (3,
4, 9, 16), although the doses of systemic opioids used
were often higher then we have observed. The most
commonly employed antiemetics were phenothiazines
followed by ondansetron. In a meta analysis of 28 ran-
domized controlled studies on IT morphine with spinal
anaesthesia, Gehling and Tryba (13) found a moderate
and clinically relevant increase in nausea/vomiting, pru-
ritus and urinary retention with IT morphine. Con-
sidering the incidence of nausea/vomiting and pruritus,
they recommended prophylaxis for these side effects.
Ondansetron, a serotonin receptor antagonist seems to
be a good choice because apart from being antiemetic, in
some studies it has been used successfully for the preven-
tion and treatment of opioid induced pruritus (18–20).
Pruritus is a well recognized side effect of opioid therapy
with the prevalence depending mainly on the method of
administration, but also on the opioid used and the pa-
tient population. The risk is much higher when opioids
are given epidurally or intraspinally compared to sys-
temic administration. In patients undergoing major or-
thopaedic surgery the reported prevalence of pruritus is
30–60 % and it seems to be dose dependent (3, 4, 6, 8, 12,
13, 16, 18). Neuraxial opioid-induced pruritus is medi-
ated centrally via ì-opioid receptors most likely in the
dorsal horn of the medulla, and naloxone is effective in
prevention and treatment of pruritus. Although antihis-
tamines are said not to be useful for this type of pruritus,
they have been used as the first choice therapy in a num-
ber of studies on orthopaedic patients (4, 7, 8, 12). Simi-
larly, we have found that the incidence of pruritus was
significantly higher in the IT morphine group (42,85%)
compared to the control group (5, 3). However, in all pa-
tients the symptoms were mild, not bothersome and no
patient requested the treatment. Beneficial effect of rec-
tal diclofenac on pruritus in patients receiving IT mor-
phine has been shown in one study, and diclofenac use
could have contributed to low grade pruritus in our study
(17).
We have not observed a case of respiratory depression
or excessive sedation defined as described in the meth-
ods, but the present study does not have the power to de-
tect such a rare events. Also, there is no clear definition of
respiratory depression. In most studies it is defined as
low respiratory frequency (respiratory rate less than 12,
10 or 8 per minute), more rarely as hypercapnia or de-
creased peripheral oxygen saturation. A depressed level
of consciousness may be even a more reliable sign of re-
spiratory depression (14, 21). The reported incidence of
respiratory depression in more recent surveys and meta
analyses varies from 3% down to less than 0,3%, the
lower incidencies beeing not higher than with systemic
administration of opioids via patient-controlled analge-
sia or i.m. injections (12–14). In earlier mentioned meta
analysis in which respiratory depression was defined as
low respiratory frequency, Gehling and Tryba (13) have
found that with IT morphine doses less than 0,3 mg
there were no more episodes of respiratory depression
than in placebo patients receiving systemic opioids. They
concluded that there were no data to support the need for
extended monitoring of patients receiving low dose spi-
nal morphine. However, allocation of patients after IT
morphine administration to regular surgical wards re-
quires established guidelines and protocols for postoper-
ative monitoring and management of these patients.
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CONCLUSION
Low dose IT morphine (0,2 mg) in combination with
regular postoperative administration of diclofenac i.v.
provides excellent analgesia in the first 24 hours after to-
tal hip and knee replacement surgery without major ad-
verse effects. The protocol we have used resulted in signi-
ficantly lower postoperative pain scores in the IT mor-
phine group with the majority of patients (76,2%) not re-
quiring any additional opioid. Mild pruritus was com-
monly associated with IT morphine use, while nausea
was a frequent side effect in both IT morphine and con-
trol group. Postoperative allocation and the need for
monitoring the patients receiving IT opioids is still a
matter of debate. The current opinion is that patients re-
ceiving low dose IT morphine without other indication
for ICU can be safely nursed on regular surgical wards
provided that the printed guidelines and protocols for
management of these patients exist. Avoiding systemic
opioid use while still providing effective postoperative
analgesia by combining IT opioids with NSAIDs could
additionally increase patient safety.
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